Healthcare - Biotechnology - NASDAQ - US
$ 9.0145
-1.48 %
$ 29.3 M
Market Cap
-0.53
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
53.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Surrozen, Inc.
SRZN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SRZN
EBIT FORECAST
EBIT Forecast Chart SRZN
NET INCOME FORECAST
Net Income Chart SRZN